Medicine Regulations Set For Improvement

Bangladesh's pharmaceutical regulatory environment is far below international standards. Medicines can be sold without current Good Manufacturing Practice (cGMP) accreditation, there is shortage of Directorate of Drug Administration (DDA) inspectors and the supply chain is interspersed with counterfeits. Given rising domestic demand for quality pharmaceuticals and a burgeoning export market, BMI fully expects positive changes to the system over the medium

To read the full article, please take a trial.